Matthew Blaseby

Matthew Blaseby is one of EIP's leading patent strategists for complex technologies, recognised for helping technology companies build patent portfolios that support commercial growth, investment, licensing and acquisition. He can offer strategic prosecution for coordinated multinational litigation, as he combines deep technical understanding with commercially focused IP strategy, ensuring that patent protection is aligned with long-term business objectives.

Over his almost 25 years as an attorney, Matthew has gained key experience in building and optimising commercially viable patent portfolios. An example is in his work for Liquivista, a spin-out of Koninklijke Philips N.V, in which he built the company's patent portfolio to approximately 1000 assets ultimately attracting significant interest from tech giants as it was bought by Samsung and later Amazon. The basis of both acquisitions was the patent portfolio Matthew had been drafting and prosecuting, as with no commercial product a key part of Liquavista’s value was its intellectual property. Matthew continued to support the portfolio following those transactions and was named one of only two European patent attorneys recommended by Amazon to handle their work directly. He also advised Nanosys, a global leader in quantum dot technology, on patent strategy and shaping an international portfolio exceeding 600 assets, including due diligence work and connected to its acquisition by Shoei Chemical.

Matthew is uniquely placed as an expert in the intersection between US and UK patent drafting and prosecution, as his work with Amazon as their in-house council lead him to develop a "transatlantic drafting style". He is now a UPC representative actively involved in the Unified Patent Court ecosystem from its development. He advises clients on how UPC litigation can be deployed alongside US strategies to create coordinated, cross-border enforcement and defence programmes.  For the last few years he has been representing a medical diagnostics client at the UPC, on a patent granted as part of his portfolio prosecution strategy.

Matthew's strength is his ability to translate patent strategy directly to business outcomes.  His work spans the full patent lifecycle, from invention harvesting and portfolio creation through prosecution, litigation support, licensing and acquisition due diligence. Thus, he can advise on fully maximising the commercial advantages of every aspect of intellectual property ownership.

‍